These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8666924

  • 1. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.
    Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH.
    J Exp Med; 1996 Apr 01; 183(4):1663-8. PubMed ID: 8666924
    [Abstract] [Full Text] [Related]

  • 2. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
    Matou-Nasri S, Gaffney J, Kumar S, Slevin M.
    Int J Oncol; 2009 Oct 01; 35(4):761-73. PubMed ID: 19724912
    [Abstract] [Full Text] [Related]

  • 3. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.
    Nandan MO, Chanchevalap S, Dalton WB, Yang VW.
    FEBS Lett; 2005 Aug 29; 579(21):4757-62. PubMed ID: 16102754
    [Abstract] [Full Text] [Related]

  • 4. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage.
    Jin P, Hardy S, Morgan DO.
    J Cell Biol; 1998 May 18; 141(4):875-85. PubMed ID: 9585407
    [Abstract] [Full Text] [Related]

  • 5. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
    Vincent I, Jicha G, Rosado M, Dickson DW.
    J Neurosci; 1997 May 15; 17(10):3588-98. PubMed ID: 9133382
    [Abstract] [Full Text] [Related]

  • 6. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
    Berdiaki A, Thrapsanioti LN, Giatagana EM, K Karamanos N, C Savani R, N Tzanakakis G, Nikitovic D.
    Mol Biol Rep; 2023 Nov 15; 50(11):8937-8947. PubMed ID: 37710072
    [Abstract] [Full Text] [Related]

  • 7. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY.
    Cancer Res; 2000 Feb 01; 60(3):542-5. PubMed ID: 10676633
    [Abstract] [Full Text] [Related]

  • 8. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
    Kawamoto H, Koizumi H, Uchikoshi T.
    Am J Pathol; 1997 Jan 01; 150(1):15-23. PubMed ID: 9006317
    [Abstract] [Full Text] [Related]

  • 9. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
    Kim MJ, Lee JY, Lee SJ.
    Oncol Rep; 2008 May 01; 19(5):1323-9. PubMed ID: 18425394
    [Abstract] [Full Text] [Related]

  • 10. Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
    Said TK, Bonnette S, Medina D.
    Cell Prolif; 1996 Nov 01; 29(11):623-39. PubMed ID: 9105418
    [Abstract] [Full Text] [Related]

  • 11. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
    Cui Z, Liao J, Cheong N, Longoria C, Cao G, DeLisser HM, Savani RC.
    Matrix Biol; 2019 May 01; 78-79():255-271. PubMed ID: 30098420
    [Abstract] [Full Text] [Related]

  • 12. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
    Nomura N, Nomura M, Newcomb EW, Zagzag D.
    Biochem Pharmacol; 2007 May 15; 73(10):1528-36. PubMed ID: 17324379
    [Abstract] [Full Text] [Related]

  • 13. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.
    De Souza CP, Ellem KA, Gabrielli BG.
    Exp Cell Res; 2000 May 25; 257(1):11-21. PubMed ID: 10854050
    [Abstract] [Full Text] [Related]

  • 14. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
    Foley JP, Lam D, Jiang H, Liao J, Cheong N, McDevitt TM, Zaman A, Wright JR, Savani RC.
    J Biol Chem; 2012 Oct 26; 287(44):37406-19. PubMed ID: 22948158
    [Abstract] [Full Text] [Related]

  • 15. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
    Niedworok C, Kretschmer I, Röck K, Vom Dorp F, Szarvas T, Heß J, Freudenberger T, Melchior-Becker A, Rübben H, Fischer JW.
    PLoS One; 2013 Oct 26; 8(9):e75681. PubMed ID: 24069434
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2.
    Hatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T, Kamata N.
    J Bone Miner Metab; 2012 May 26; 30(3):293-303. PubMed ID: 21947782
    [Abstract] [Full Text] [Related]

  • 17. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM, Molla K, Anandharaj A, Cornax I, O Sullivan MG, Kirtane AR, Panyam J, Kassie F.
    Oncotarget; 2017 Apr 18; 8(16):26927-26940. PubMed ID: 28460475
    [Abstract] [Full Text] [Related]

  • 18. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
    Leng Y, Abdullah A, Wendt MK, Calve S.
    Matrix Biol; 2019 May 18; 78-79():236-254. PubMed ID: 30130585
    [Abstract] [Full Text] [Related]

  • 19. p53 regulates a G2 checkpoint through cyclin B1.
    Innocente SA, Abrahamson JL, Cogswell JP, Lee JM.
    Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):2147-52. PubMed ID: 10051609
    [Abstract] [Full Text] [Related]

  • 20. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells.
    Jin P, Gu Y, Morgan DO.
    J Cell Biol; 1996 Aug 02; 134(4):963-70. PubMed ID: 8769420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.